Sustainability is now a business imperative. With the environmental bar set ever higher and investors’ expectations rising, sustainability is crucial for supplier selection and evaluation and a must for bio/pharmaceutical companies, CDMOs/CMOs, and other suppliers.

To address both the opportunities and challenges on this topic, the Drug, Chemical & Associated Technologies Association (DCAT) is bringing together high-level business executives and policy leaders for its inaugural two-day conference and networking event to provide specific, concrete, and innovative approaches to resolving sustainability challenges arising in the Bio/Pharmaceutical customer-supplier relationship.